219 related articles for article (PubMed ID: 28545141)
1. Prion pathogenesis is unaltered in the absence of SIRPα-mediated "don't-eat-me" signaling.
Nuvolone M; Paolucci M; Sorce S; Kana V; Moos R; Matozaki T; Aguzzi A
PLoS One; 2017; 12(5):e0177876. PubMed ID: 28545141
[TBL] [Abstract][Full Text] [Related]
2. Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype.
Pankiewicz JE; Lizińczyk AM; Franco LA; Diaz JR; Martá-Ariza M; Sadowski MJ
Acta Neuropathol Commun; 2021 Sep; 9(1):157. PubMed ID: 34565486
[TBL] [Abstract][Full Text] [Related]
3. Unaltered prion disease in mice lacking developmental endothelial locus-1.
Zhu C; Li Z; Li B; Pfammatter M; Hornemann S; Aguzzi A
Neurobiol Aging; 2019 Apr; 76():208-213. PubMed ID: 30743056
[TBL] [Abstract][Full Text] [Related]
4. A neuroprotective role for microglia in prion diseases.
Zhu C; Herrmann US; Falsig J; Abakumova I; Nuvolone M; Schwarz P; Frauenknecht K; Rushing EJ; Aguzzi A
J Exp Med; 2016 May; 213(6):1047-59. PubMed ID: 27185853
[TBL] [Abstract][Full Text] [Related]
5. Microglia in prion diseases.
Aguzzi A; Zhu C
J Clin Invest; 2017 Sep; 127(9):3230-3239. PubMed ID: 28714865
[TBL] [Abstract][Full Text] [Related]
6. SIRPα polymorphisms, but not the prion protein, control phagocytosis of apoptotic cells.
Nuvolone M; Kana V; Hutter G; Sakata D; Mortin-Toth SM; Russo G; Danska JS; Aguzzi A
J Exp Med; 2013 Nov; 210(12):2539-52. PubMed ID: 24145514
[TBL] [Abstract][Full Text] [Related]
7. Effect of Microglial Inflammation in Prion Disease.
Ano Y; Sakudo A; Onodera T
Curr Issues Mol Biol; 2020; 36():1-12. PubMed ID: 31486773
[TBL] [Abstract][Full Text] [Related]
8. CD11c is not required by microglia to convey neuroprotection after prion infection.
Carroll JA; Striebel JF; Baune C; Chesebro B; Race B
PLoS One; 2023; 18(11):e0293301. PubMed ID: 37910561
[TBL] [Abstract][Full Text] [Related]
9. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
Carroll JA; Race B; Williams K; Striebel J; Chesebro B
Mol Brain; 2020 May; 13(1):71. PubMed ID: 32381108
[TBL] [Abstract][Full Text] [Related]
10. The role of macrophage scavenger receptor 1 (Msr1) in prion pathogenesis.
Li B; Chen M; Aguzzi A; Zhu C
J Mol Med (Berl); 2021 Jun; 99(6):877-887. PubMed ID: 33758958
[TBL] [Abstract][Full Text] [Related]
11. Re-infection of the prion from the scrapie‑infected cell line SMB-S15 in three strains of mice, CD1, C57BL/6 and Balb/c.
Xiao K; Zhang BY; Zhang XM; Wang J; Chen C; Chen LN; Lv Y; Shi Q; Dong XP
Int J Mol Med; 2016 Mar; 37(3):716-26. PubMed ID: 26820255
[TBL] [Abstract][Full Text] [Related]
12. Microglia deficiency accelerates prion disease but does not enhance prion accumulation in the brain.
Bradford BM; McGuire LI; Hume DA; Pridans C; Mabbott NA
Glia; 2022 Nov; 70(11):2169-2187. PubMed ID: 35852018
[TBL] [Abstract][Full Text] [Related]
13. Effects of prion protein devoid of the N-terminal residues 25-50 on prion pathogenesis in mice.
Das NR; Miyata H; Hara H; Uchiyama K; Chida J; Yano M; Watanabe H; Kondoh G; Sakaguchi S
Arch Virol; 2017 Jul; 162(7):1867-1876. PubMed ID: 28255815
[TBL] [Abstract][Full Text] [Related]
14. The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment.
Iwamoto C; Takenaka K; Urata S; Yamauchi T; Shima T; Kuriyama T; Daitoku S; Saito Y; Miyamoto T; Iwasaki H; Kitabayashi I; Itoh K; Kishimoto J; Kohda D; Matozaki T; Akashi K
Exp Hematol; 2014 Mar; 42(3):163-171.e1. PubMed ID: 24269920
[TBL] [Abstract][Full Text] [Related]
15. Triggering receptor expressed on myeloid cells-2 is involved in prion-induced microglial activation but does not contribute to prion pathogenesis in mouse brains.
Zhu C; Herrmann US; Li B; Abakumova I; Moos R; Schwarz P; Rushing EJ; Colonna M; Aguzzi A
Neurobiol Aging; 2015 May; 36(5):1994-2003. PubMed ID: 25816748
[TBL] [Abstract][Full Text] [Related]
16. SIRPα deficiency accelerates the pathologic process in models of Parkinson disease.
Wang J; Ding X; Wu X; Liu J; Zhou R; Wei P; Zhang Q; Zhang C; Zen K; Li L
Glia; 2019 Dec; 67(12):2343-2359. PubMed ID: 31322787
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of CD47/SIRPα signaling protects cones in genetic models of retinal degeneration.
Wang SK; Xue Y; Cepko CL
JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34197341
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of specific protein 1 (SP1) by hypoxia-inducible factor 1 alpha (HIF-1α) leads to PRNP expression and neuroprotection from toxic prion peptide.
Jeong JK; Park SY
Biochem Biophys Res Commun; 2012 Dec; 429(1-2):93-8. PubMed ID: 23131565
[TBL] [Abstract][Full Text] [Related]
19. Accelerated prion replication in, but prolonged survival times of, prion-infected CXCR3-/- mice.
Riemer C; Schultz J; Burwinkel M; Schwarz A; Mok SW; Gültner S; Bamme T; Norley S; van Landeghem F; Lu B; Gerard C; Baier M
J Virol; 2008 Dec; 82(24):12464-71. PubMed ID: 18842729
[TBL] [Abstract][Full Text] [Related]
20. Activation of microglia by retroviral infection correlates with transient clearance of prions from the brain but does not change incubation time.
Muth C; Schröck K; Madore C; Hartmann K; Fanek Z; Butovsky O; Glatzel M; Krasemann S
Brain Pathol; 2017 Sep; 27(5):590-602. PubMed ID: 27558169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
